UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 521

Sortiert nach

Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153

Journal of clinical oncology, 2020-11, Vol.38 (33), p.3863-3873

2020

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer

Journal of clinical oncology, 2016-08, Vol.34 (23), p.2712-2720

2016

Link zum Volltext

Verfügbarkeit prüfen

2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting

Supportive care in cancer, 2017-01, Vol.25 (1), p.303-308

2017

Link zum Volltext

Verfügbarkeit prüfen

Curing Metastatic Testicular Cancer

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (7), p.4592-4595

Einhorn, Lawrence H.

2002

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors

The New England journal of medicine, 2007-07, Vol.357 (4), p.340-348

2007

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Antagonist and Dexamethasone in Patients With Germ Cell Tumors Receiving 5-Day Cisplatin Combination Chemotherapy Regimens: A Hoosier Oncology Group Study

Journal of clinical oncology, 2012-11, Vol.30 (32), p.3998-4003

2012

Link zum Volltext

Verfügbarkeit prüfen

American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors

Journal of clinical oncology, 2010-07, Vol.28 (20), p.3388-3404

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer

Clinical cancer research, 2017-10, Vol.23 (19), p.5757-5768

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients With Disseminated Nonseminomatous Germ Cell Tumors: Is a Postchemotherapy Retroperitoneal Lymph Node Dissection Needed After Complete Remission?

Journal of clinical oncology, 2010-02, Vol.28 (4), p.531-536

2010

Link zum Volltext

Verfügbarkeit prüfen

Testicular cancer: a reflection on 50 years of discovery

Journal of clinical oncology, 2014-10, Vol.32 (28), p.3085-3092

2014

Link zum Volltext

Verfügbarkeit prüfen

Testicular Cancer — Discoveries and Updates

The New England journal of medicine, 2014-11, Vol.371 (21), p.2005-2016

2014

Link zum Volltext

Verfügbarkeit prüfen

Randomized Pilot Trial of a Telephone Symptom Management Intervention for Symptomatic Lung Cancer Patients and Their Family Caregivers

Journal of pain and symptom management, 2016-10, Vol.52 (4), p.469-482

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors

Clinical cancer research, 2020-12, Vol.26 (24), p.6550-6558

2020

Link zum Volltext

Verfügbarkeit prüfen

Testicular Cancer: Biology to Bedside

Cancer research (Chicago, Ill.), 2021-11, Vol.81 (21), p.5369-5376

2021

Link zum Volltext

Verfügbarkeit prüfen

Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine

Oncotarget, 2017-01, Vol.8 (2), p.2949-2959

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors

Investigational new drugs, 2021-12, Vol.39 (6), p.1656-1663

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing

Journal of clinical oncology, 2001-06, Vol.19 (11), p.2875-2882

2001

Link zum Volltext

Verfügbarkeit prüfen

Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers

Oncotarget, 2016-08, Vol.7 (35), p.56491-56500

2016

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy

Journal of cancer survivorship, 2023-02, Vol.17 (1), p.27-39

2023

Link zum Volltext

Verfügbarkeit prüfen

Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2006-09, Vol.24 (27), p.4405-4411

2006

Link zum Volltext

Verfügbarkeit prüfen

Barriers to mental health service use and preferences for addressing emotional concerns among lung cancer patients

Psycho-oncology (Chichester, England), 2014-07, Vol.23 (7), p.812-819

2014

Link zum Volltext

Verfügbarkeit prüfen

The “growing teratoma syndrome” in primary mediastinal nonseminomatous germ cell tumors: Criteria based on current practice

The Journal of thoracic and cardiovascular surgery, 2012-08, Vol.144 (2), p.438-443

2012

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience

Journal of clinical oncology, 2017-04, Vol.35 (10), p.1096-1102

2017

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study

Supportive care in cancer, 2007-11, Vol.15 (11), p.1285-1285, Article 1285

2007

Link zum Volltext

Verfügbarkeit prüfen

Extragonadal germ cell tumors: clinical presentation and management

Current opinion in oncology, 2013-05, Vol.25 (3), p.261-265

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 521

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(495)
Mit Volltextzugriff
(449)

Publikationsform

Sprache

Englisch
(520)
Japanisch
(61)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(327)
Science & Technology
(324)
Life Sciences & Biomedicine
(319)
Male
(264)
Oncology
(236)
Adult
(184)
Middle Aged
(146)
Biological And Medical Sciences
(135)
Medical Sciences
(135)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(112)
Testicular Neoplasms - Drug Therapy
(98)
Female
(93)
Chemotherapy
(86)
Adolescent
(80)
Aged
(78)
Cisplatin - Administration & Dosage
(72)
Tumors
(70)
Pharmacology. Drug Treatments
(67)
Testicular Neoplasms - Pathology
(64)
Retrospective Studies
(62)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer

2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting

Curing Metastatic Testicular Cancer

High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors

American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors

Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer

Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients With Disseminated Nonseminomatous Germ Cell Tumors: Is a Postchemotherapy Retroperitoneal Lymph Node Dissection Needed After Complete Remission?

Testicular cancer: a reflection on 50 years of discovery

Testicular Cancer — Discoveries and Updates

Randomized Pilot Trial of a Telephone Symptom Management Intervention for Symptomatic Lung Cancer Patients and Their Family Caregivers

Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors

Testicular Cancer: Biology to Bedside

Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine

Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors

Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing

Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers

Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy

Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Barriers to mental health service use and preferences for addressing emotional concerns among lung cancer patients

The “growing teratoma syndrome” in primary mediastinal nonseminomatous germ cell tumors: Criteria based on current practice

High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience

A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study

Extragonadal germ cell tumors: clinical presentation and management

Suchergebnisse filtern